FDA Approves Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the Treatment of Neuroblastoma

    NEXT STORY
    Molecular Diagnostics Market to Record over 7% Growth Rate and Hit USD 13873.6 Million by 2025; Advancements in this Field to Increase Productivity Level, states Fortune Business Insights™
    PREV STORY
    CB2 Insights Announces Results of Special Shareholders Meeting and Schedule for Q3 2020 Earnings Call
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    The Rumphius Foundation Awards Grants to Solar Youth & The Charles River Conservancy

    Boston, Massachusetts, Sept. 25, 2017 (GLOBE NEWSWIRE) -- The Rumphius Foundation, a non-profit organization ...

    author_avatar
    NASDAQ Market News

    Global Oral Vaccine Market (2019 to 2025) – Industry Analysis, Trends, Market Size and Forecasts

    author_avatar
    NASDAQ Market News

    INNATE PHARMA: consolidated financial results for the year ended December 31, 2017

    2017: CLINiCAL PROGRESS, Portfolio expansion and financial strength create the foundation for future growth ...

    author_avatar
    NASDAQ Market News